Beta blockers and the failing heart: is it time for a U-turn?
作者信息
Bashir Y, McKenna W J, Camm A J
机构信息
Department of Cardiological Sciences, St George's Hospital, Medical School, London.
出版信息
Br Heart J. 1993 Jul;70(1):8-12. doi: 10.1136/hrt.70.1.8.
Abstract
摘要
相似文献
1
Beta blockers and the failing heart: is it time for a U-turn?β受体阻滞剂与衰竭心脏：是时候转向了吗？
Br Heart J. 1993 Jul;70(1):8-12. doi: 10.1136/hrt.70.1.8.
2
Beta-blockers and heart failure.β受体阻滞剂与心力衰竭
Health News. 2000 Apr;6(4):8.
3
Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.一种新型强心剂——普瑞特罗——治疗低血压和心力衰竭的临床经验。
Clin Cardiol. 1980 Apr;3(2):96-105.
4
The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials.心力衰竭试验最佳临床终点的持续演变
JACC Heart Fail. 2015 Aug;3(8):615-7. doi: 10.1016/j.jchf.2015.04.010.
5
6
Treatment of heart failure with beta-blockers. Mechanisms and results.β受体阻滞剂治疗心力衰竭。作用机制与治疗结果。
Basic Res Cardiol. 2000;95 Suppl 1:I15-24. doi: 10.1007/s003950070004.
7
The effect of beta-blockers on morbidity and mortality associated with heart failure.β受体阻滞剂对心力衰竭相关发病率和死亡率的影响。
Am J Manag Care. 2000 Apr;6(6 Suppl):S308-12.
8
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.心力衰竭生理学、病理生理学及临床意义中的交感神经系统
J Am Coll Cardiol. 2009 Nov 3;54(19):1747-62. doi: 10.1016/j.jacc.2009.05.015.
9
Beta-blockade in heart failure. Basic concepts and clinical results.心力衰竭中的β受体阻滞剂。基本概念与临床结果。
Am J Hypertens. 1998 Jan;11(1 Pt 2):23S-37S. doi: 10.1016/s0895-7061(97)00425-1.
10
Beta-blockers in heart failure: potential of carvedilol.心力衰竭中的β受体阻滞剂：卡维地洛的潜力。
J Hum Hypertens. 1993 Feb;7 Suppl 1:S62-7.
引用本文的文献
1
Medical treatment beyond ACE inhibition: false promise or lack of vision?除血管紧张素转换酶抑制剂之外的医学治疗：虚假承诺还是缺乏远见？
Br Heart J. 1994 Sep;72(3 Suppl):S100-5. doi: 10.1136/hrt.72.3_suppl.s100.
2
Clinical implications of the interval-force relationship of the heart.心脏间期-力关系的临床意义。
Postgrad Med J. 1994 Aug;70(826):553-7. doi: 10.1136/pgmj.70.826.553.
3
Nitric oxide mediated venodilator effects of nebivolol.奈必洛尔的一氧化氮介导的静脉舒张作用。
Br J Clin Pharmacol. 1994 Sep;38(3):199-204. doi: 10.1111/j.1365-2125.1994.tb04342.x.
本文引用的文献
1
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy.肾上腺素的肾上腺色素代谢产物所致的心室功能障碍与坏死：与儿茶酚胺心肌病发病机制的关系
Am Heart J. 1981 Aug;102(2):210-21. doi: 10.1016/s0002-8703(81)80012-9.
2
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.血浆去甲肾上腺素作为慢性充血性心力衰竭患者预后的一项指标。
N Engl J Med. 1984 Sep 27;311(13):819-23. doi: 10.1056/NEJM198409273111303.
3
The relationship between the strength of the human heart beat and the interval between beats.人类心跳强度与心跳间隔之间的关系。
Circulation. 1982 Jun;65(7):1404-10. doi: 10.1161/01.cir.65.7.1404.
4
Beta-adrenergic blockage in congestive cardiomyopathy.充血性心肌病中的β-肾上腺素能阻滞
Lancet. 1980 May 10;1(8176):1031.
5
Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.美托洛尔口服β受体阻滞剂治疗慢性重度扩张型心肌病
J Am Coll Cardiol. 1984 Jan;3(1):203-9. doi: 10.1016/s0735-1097(84)80449-0.
6
Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.充血性心肌病慢性口服β受体阻滞剂的双盲试验
Lancet. 1981 Sep 5;2(8245):490-3. doi: 10.1016/s0140-6736(81)90881-3.
7
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.充血性心肌病患者停用β受体阻滞剂的不良反应。
Br Heart J. 1980 Aug;44(2):134-42. doi: 10.1136/hrt.44.2.134.
8
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.长期使用β受体阻滞剂对充血性心肌病的有益作用。
Br Heart J. 1980 Aug;44(2):117-33. doi: 10.1136/hrt.44.2.117.
9
Focal myocarditis associated with pheochromocytoma.与嗜铬细胞瘤相关的局灶性心肌炎。
N Engl J Med. 1966 May 19;274(20):1102-8. doi: 10.1056/NEJM196605192742002.
10
Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.钙超载作为儿茶酚胺诱导心肌损伤产生的决定性因素。
Recent Adv Stud Cardiac Struct Metab. 1973;2:455-66.
Zotero 插件